DOD-CDMRP: Amyotrophic Lateral Sclerosis Research Program - Therapeutic Development Award

Supports preclinical development of therapeutics for ALS; Specific focus areas include development of high-throughput screens up to the submission of IND for later clinical trials. Clinical trials are not allowed under this mechanism. Funding $1,500,000 over 3 years. More cost-effective studies not requesting the full funding amount are encouraged. Pre-proposal.